Insulin Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 109 amino acids (25-110 a.a) and having a molecular mass of 11.8kDa. Insulin is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Insulin, Insulin-Dependent Diabetes Mellitus 2, Preproinsulin, Proinsulin, MODY10, IDDM1, IDDM2, IDDM, ILPR, IRDN.
MGSSHHHHHH SSGLVPRGSH MGSFVNQHLC GSHLVEALYL VCGERGFFYT PKTRREAEDL QVGQVELGGG PGAGSLQPLA LEGSLQKRGI VEQCCTSICS LYQLENYCN
Human insulin is a peptide hormone consisting of 51 amino acids organized into two chains: an A chain (21 amino acids) and a B chain (30 amino acids) connected by disulfide bonds . The precise sequence of the A chain is GIVEQCCTSICSLYQLENYCN, while the B chain sequence is FVNQHLCGSHLVEALYLVCGERGFFYTPKT . The molecular formula is C257H383N65O77S6 with an average weight of 5808.0 Da .
The three-dimensional structure of insulin is critical for its biological activity, particularly the areas that interact with the insulin receptor. In experimental research, understanding this structure is fundamental because:
The tertiary structure determines receptor binding affinity and specificity
Disulfide bond integrity affects stability and biological activity
The C-terminal region of the B-chain undergoes conformational changes during receptor binding
Small modifications in the amino acid sequence can significantly alter pharmacokinetic properties
Researchers should note that the structure-function relationship makes human insulin an excellent model for studying protein-receptor interactions and for designing insulin analogs with modified properties for specific experimental purposes .
Human insulin regulates cellular metabolism through several interconnected pathways that researchers should consider in experimental design:
Primary Signal Transduction Pathway:
Insulin binds to the insulin receptor (IR), a heterotetrameric protein with two extracellular α-subunits and two transmembrane β-subunits
Binding activates the tyrosine kinase activity of the β-subunits, initiating autophosphorylation
The activated receptor phosphorylates intracellular substrates including insulin receptor substrates (IRS), Cbl, APS, Shc, and Gab 1
These activated proteins lead to downstream activation of PI3 kinase and Akt
Akt regulates glucose transporter 4 (GLUT4) and protein kinase C (PKC), which play critical roles in metabolism
Metabolic Effects in Target Tissues:
Tissue | Primary Insulin Actions | Experimental Considerations |
---|---|---|
Skeletal Muscle | Glucose uptake via GLUT4 translocation; glycogen synthesis; protein synthesis | Constitutes ~70% of insulin-stimulated glucose disposal; key tissue for studying insulin resistance |
Adipose Tissue | Glucose uptake; lipogenesis; inhibition of lipolysis | Important for studying metabolic syndrome and obesity-related insulin resistance |
Liver | Inhibition of gluconeogenesis; promotion of glycogen synthesis; lipogenesis | Central for glucose homeostasis research; exhibits direct and indirect insulin effects |
Brain | Enhanced learning and memory; regulation of appetite | Increasingly recognized as an insulin-responsive tissue with implications for cognitive research |
For rigorous experimental design, researchers should account for the tissue-specific nature of insulin signaling and the complex crosstalk between metabolic pathways .
Understanding insulin secretion regulation is essential for designing experiments that accurately reflect physiological conditions:
Glucose-Dependent Regulation:
Threshold effect: Insulin secretion is initiated at glucose concentrations above 5 mM, while insulin biosynthesis occurs at lower concentrations (2-4 mM)
Beta cells sense glucose through metabolism-dependent mechanisms involving KATP channels
Glucose metabolism increases ATP:ADP ratio, closing KATP channels and depolarizing the cell membrane
Depolarization triggers calcium influx through voltage-dependent calcium channels, stimulating insulin exocytosis
Incretin-Mediated Regulation:
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) enhance glucose-stimulated insulin secretion
These incretin hormones bind to G-protein-coupled receptors on β-cell membranes
This increases cellular cAMP levels and potentiates glucose-stimulated insulin secretion
Incretin action is independent of KATP channel closure, providing an additional regulatory pathway
Other Regulatory Factors:
Amino acids (particularly arginine and leucine) stimulate insulin secretion
Neural regulation via parasympathetic and sympathetic inputs
Hormonal modulation by glucagon, somatostatin, and stress hormones
When designing experiments involving insulin secretion, researchers should carefully consider:
The glucose concentration used (fasting vs. stimulatory levels)
The presence or absence of incretins in the experimental system
The potential influence of neural and hormonal factors
Researchers investigating insulin require reliable methods to measure insulin activity:
In Vitro Assays:
Receptor Binding Assays:
Competitive binding assays using radiolabeled insulin and cell lines expressing insulin receptors
Surface plasmon resonance for real-time binding kinetics
FRET-based approaches for investigating conformational changes
Signaling Pathway Activation:
Western blotting for phosphorylation of insulin receptor and downstream targets (IRS, Akt)
Phospho-specific ELISA for quantitative measurement of signaling activation
Immunofluorescence for spatial distribution of signaling events
Live-cell imaging with fluorescent biosensors for real-time pathway activation
Metabolic Readouts:
Glucose uptake assays using radiolabeled or fluorescent glucose analogs
Glycogen synthesis measurement
Lipogenesis assays measuring incorporation of labeled acetate or glucose
Protein synthesis determination using labeled amino acids
Ex Vivo and In Vivo Methods:
Islet Perifusion Studies:
Real-time measurement of insulin secretion from isolated islets
Allows evaluation of dynamic insulin secretion in response to various stimuli
Hyperinsulinemic-Euglycemic Clamp:
Gold standard for assessing insulin sensitivity in vivo
Measures the glucose infusion rate required to maintain euglycemia during insulin infusion
Insulin Tolerance Test:
Measures blood glucose decrease following insulin administration
Provides a practical index of whole-body insulin sensitivity
When selecting methodologies, researchers should consider the specific aspect of insulin action they are investigating and choose appropriate positive and negative controls to ensure assay validity .
Insulin's effects extend beyond glucose metabolism, creating challenges and opportunities for complex physiological research:
Cardiovascular Effects:
Insulin influences vascular compliance and endothelial function
Promotes vasodilation through nitric oxide production
Affects sodium reabsorption in the kidneys, influencing blood pressure regulation
Neurological Functions:
Enhances learning and memory, particularly verbal memory
Contributes to thermoregulatory and glucoregulatory responses to food intake
Impacts central nervous system function through specific receptors in various brain regions
Reproductive System Effects:
Stimulates gonadotropin-releasing hormone from the hypothalamus
Influences fertility and reproductive function
Methodological Considerations for Researchers:
Research Area | Confounding Factors | Recommended Controls |
---|---|---|
Metabolism Studies | Non-metabolic insulin effects altering energy homeostasis | Time-matched experiments; specific pathway inhibitors |
Cardiovascular Research | Direct vascular effects vs. metabolic improvements | Pathway-specific interventions; hyperinsulinemic-euglycemic clamps |
Neuroscience Investigations | Central vs. peripheral insulin actions | Brain-specific insulin receptor manipulations; intranasal insulin administration |
Reproductive Studies | Interaction with sex hormones | Sex-stratified analyses; gonadectomy models with hormone replacement |
Researchers should implement experimental designs that can distinguish direct insulin effects from indirect consequences of improved metabolism. This might include:
Using specific insulin receptor antagonists
Employing tissue-specific insulin receptor knockout models
Comparing insulin to non-insulin glucose-lowering interventions
Implementing time-course studies to separate rapid signaling from transcriptional effects
Insulin resistance represents a major research area with important methodological considerations:
Molecular Mechanisms:
Receptor-Level Defects:
Decreased insulin receptor expression
Impaired insulin binding
Reduced receptor autophosphorylation
Post-Receptor Signaling Defects:
Increased serine/threonine phosphorylation of IRS proteins
Reduced PI3K activation and PIP3 generation
Impaired Akt phosphorylation and activation
Defective GLUT4 translocation
Inflammatory Mechanisms:
Activation of inflammatory kinases (JNK, IKK, PKC isoforms)
Increased cytokine signaling interfering with insulin pathways
Macrophage infiltration in metabolic tissues
Lipid-Mediated Mechanisms:
Diacylglycerol activation of novel PKC isoforms
Ceramide inhibition of Akt
Altered membrane lipid composition affecting receptor function
Experimental Models for Insulin Resistance:
Model Type | Advantages | Limitations | Methodological Considerations |
---|---|---|---|
Cell Culture | Precise molecular manipulation; high throughput | Lacks systemic factors; acute rather than chronic | Use physiological insulin concentrations (0.1-10 nM); include appropriate time courses |
Palmitate-Induced | Mimics lipotoxicity; rapid induction | May not reflect all aspects of insulin resistance | Control fatty acid composition and albumin binding; monitor cell viability |
Hyperinsulinemia-Induced | Reflects physiological downregulation | Can be difficult to distinguish from toxicity | Use pulsatile rather than constant insulin exposure |
Genetic Models (in vivo) | Tissue-specific manipulation possible | Compensatory mechanisms may develop | Inducible systems can reduce developmental adaptations |
Diet-Induced (in vivo) | Closely mimics human pathophysiology | Strain-dependent responses; long induction times | Control for changes in body composition; pair-feeding may be necessary |
When designing insulin resistance studies, researchers should:
Validate insulin resistance using multiple readouts (signaling, glucose uptake, metabolic effects)
Consider tissue-specific differences in insulin resistance mechanisms
Account for the time-dependent progression of insulin resistance
Include controls for confounding factors like inflammation, oxidative stress, and ER stress
Insulin exerts both rapid non-genomic effects and longer-term genomic effects, presenting methodological challenges:
Characteristics of Genomic vs. Non-Genomic Actions:
Parameter | Genomic Actions | Non-Genomic Actions |
---|---|---|
Time Course | Hours (typically >2h) | Seconds to minutes (<30 min) |
Mechanisms | Transcriptional regulation | Protein phosphorylation; vesicle translocation |
Inhibition | Blocked by transcription/translation inhibitors | Resistant to transcription/translation inhibitors |
Concentration Required | Often effective at physiological concentrations | May require higher concentrations for some effects |
Receptor Dependence | Typically canonical insulin receptor-dependent | May involve insulin receptor or alternative receptors/pathways |
Methodological Approaches:
Temporal Discrimination:
Perform detailed time-course experiments from seconds to hours
Compare rapid effects (glucose transport, enzyme activity) with delayed responses (protein synthesis, gene expression)
Use pulse-chase experimental designs to separate initial signaling from downstream consequences
Pharmacological Tools:
Apply transcription inhibitors (actinomycin D) or translation inhibitors (cycloheximide) to block genomic effects
Use pathway-specific inhibitors to dissect signaling cascades
Employ receptor antagonists to determine receptor specificity
Genetic Approaches:
Utilize cells with mutated insulin receptors that maintain non-genomic signaling but lack genomic effects
Implement CRISPR-Cas9 to modify specific signaling nodes
Develop inducible expression systems for controlled temporal studies
Advanced Techniques:
Real-time imaging with fluorescent biosensors for immediate signaling events
Chromatin immunoprecipitation to detect insulin-regulated transcription factor binding
Ribosome profiling to assess translational effects
Phosphoproteomics to capture early signaling events comprehensively
Researchers should design experiments with appropriate controls to account for:
Potential crosstalk between genomic and non-genomic pathways
Tissue-specific variations in insulin action mechanisms
Concentration-dependent effects that may engage different pathways
The influence of experimental conditions (cell confluency, serum starvation, etc.) on insulin responsiveness
Researchers frequently encounter contradictory findings when studying insulin signaling across different models:
Common Sources of Data Contradictions:
Model-Specific Differences:
Species variations in insulin signaling components
Differences between primary cells and immortalized cell lines
Variations in receptor/pathway component expression levels
Altered metabolic states of different models
Methodological Variations:
Differences in insulin concentrations used (physiological vs. pharmacological)
Varied duration of insulin stimulation
Diverse cell culture conditions (glucose concentration, serum components)
Different analytical techniques and their sensitivity/specificity
Systematic Approaches to Resolve Contradictions:
Cross-Model Validation:
Systematically test hypotheses across multiple models under standardized conditions
Include appropriate positive and negative controls for each model
Directly compare primary cells to cell lines when possible
Validate in vitro findings in ex vivo or in vivo systems
Standardization of Methodology:
Establish dose-response relationships for insulin in each model
Perform detailed time-course studies to capture both early and late responses
Control for cell density, passage number, and culture conditions
Normalize signaling responses to receptor expression levels
Comprehensive Pathway Analysis:
Examine multiple nodes within signaling pathways rather than single endpoints
Utilize phospho-specific antibodies to assess activation states
Implement mass spectrometry-based phosphoproteomics for unbiased assessment
Consider pathway crosstalk and compensatory mechanisms
Advanced Statistical Approaches:
Apply meta-analysis techniques to integrate findings across studies
Use multivariate analysis to identify covariates affecting insulin responses
Implement Bayesian approaches to incorporate prior knowledge
Develop mathematical models to predict context-dependent signaling outcomes
To effectively address contradictions, researchers should:
Clearly report all experimental conditions in publications
Include detailed methods sections with critical parameters
Consider biological context when interpreting results
Acknowledge limitations of specific models
Design experiments that directly test alternative hypotheses
Insulin coordinates metabolism across multiple tissues, presenting unique research challenges:
Tissue-Specific Insulin Actions and Their Integration:
Tissue | Primary Insulin Actions | Integration with Other Tissues |
---|---|---|
Liver | Suppresses gluconeogenesis; promotes glycogen synthesis and lipogenesis | Releases glucose/VLDL to fuel peripheral tissues; responds to muscle-derived amino acids |
Skeletal Muscle | Stimulates glucose uptake and glycogen synthesis; promotes protein synthesis | Releases amino acids during insulin deficiency; lactate production affects liver metabolism |
Adipose Tissue | Promotes glucose uptake and lipogenesis; inhibits lipolysis | Releases or stores FFAs affecting muscle/liver insulin sensitivity; secretes adipokines |
Brain | Regulates appetite and autonomic outputs; affects cognition | Controls neural signals to liver, muscle, and adipose; regulates counter-regulatory hormone release |
Pancreas | Suppresses glucagon secretion from α cells | Determines insulin:glucagon ratio affecting all other tissues |
Methodological Approaches:
Integrated In Vivo Techniques:
Hyperinsulinemic-euglycemic clamps with tissue-specific glucose uptake measurements
Arterio-venous difference measurements across tissue beds
Stable isotope tracer studies to track metabolic fluxes
Metabolic cages for continuous assessment of whole-body metabolism
Ex Vivo Organ Crosstalk:
Conditioned media experiments transferring secreted factors between tissues
Co-culture systems with multiple cell types
Microfluidic "organ-on-chip" approaches with connected tissue compartments
Perifusion systems for dynamic secretion studies
In Vivo Tissue-Specific Manipulations:
Tissue-specific insulin receptor knockout models
Viral vector-mediated gene delivery to specific tissues
Inducible, tissue-specific transgene expression
Selective inhibition of tissue-specific insulin action using antisense oligonucleotides
Systems Biology Approaches:
Multi-omics integration (transcriptomics, proteomics, metabolomics)
Computational modeling of cross-tissue metabolic fluxes
Agent-based modeling of tissue interactions
Network analysis of hormone signaling integration
Researchers studying multi-tissue integration should:
Design studies that simultaneously assess multiple tissues
Consider the temporal sequence of insulin actions across tissues
Account for fed/fasted state differences in tissue insulin sensitivity
Recognize that perturbations in one tissue can have secondary effects on others
Integrate findings from reductionist models into a systems-level understanding of metabolism
Recent research has expanded our understanding of insulin's functions beyond classical metabolic regulation:
Emerging Non-Traditional Roles of Insulin:
Neurocognitive Functions:
Immune System Modulation:
Cellular Stress Responses:
Modulates endoplasmic reticulum stress
Influences autophagy and proteostasis
Affects cellular senescence pathways
Regulates mitochondrial dynamics and function
Epigenetic Regulation:
Alters DNA methylation patterns
Influences histone modifications
Regulates non-coding RNA expression
Contributes to metabolic memory phenomena
Advanced Methodological Approaches:
Research Area | Cutting-Edge Techniques | Methodological Considerations |
---|---|---|
Neurocognitive | Optogenetic manipulation of insulin-responsive neurons; in vivo microdialysis with neurotransmitter measurement; functional neuroimaging during insulin administration | Brain-specific insulin delivery (e.g., intranasal); controlling for systemic metabolic effects |
Immunometabolic | Single-cell metabolic profiling of immune cells; isotope tracing in specific immune populations; spatial transcriptomics of tissue-resident immune cells | Maintaining physiological insulin concentrations; accounting for indirect effects through glucose modulation |
Stress Responses | Live-cell imaging of stress responses; proximity labeling of insulin-regulated stress proteins; stress-specific organoid models | Distinguishing direct insulin effects from adaptive responses to metabolic changes |
Epigenetics | ChIP-seq for insulin-regulated transcription factors; ATAC-seq for chromatin accessibility; single-cell multi-omics approaches | Temporal considerations (acute vs. chronic insulin exposure); tissue-specific epigenetic responses |
For researchers exploring these frontier areas, recommended approaches include:
Combining targeted and unbiased screening approaches
Implementing single-cell technologies to address cellular heterogeneity
Developing tissue-specific insulin resistance models that preserve insulin action in tissues of interest
Utilizing conditional knockout strategies with temporal control
Applying systems biology approaches to integrate diverse datasets
Adapting methods from specialized fields (neuroscience, immunology, etc.) to insulin research questions
Insulin is a crucial hormone produced by the pancreas that regulates glucose levels in the blood. It facilitates the uptake of glucose into cells, thereby providing them with energy. Insulin deficiency or resistance leads to diabetes, a condition that affects millions worldwide.
Recombinant human insulin is a form of insulin that is produced using recombinant DNA technology. This method involves inserting the human insulin gene into bacteria or yeast, which then produce insulin that can be harvested and purified. This technology has revolutionized diabetes treatment by providing a consistent and reliable source of insulin.
His Tag (Histidine Tag) is a sequence of histidine residues added to proteins to facilitate their purification. The His tag binds to nickel ions, allowing the tagged protein to be separated from other cellular components using a technique called affinity chromatography.